METADATE ER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metadate Er, and when can generic versions of Metadate Er launch?
Metadate Er is a drug marketed by Lannett Co Inc and is included in two NDAs.
The generic ingredient in METADATE ER is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metadate Er
A generic version of METADATE ER was approved as methylphenidate hydrochloride by SPECGX LLC on November 27th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METADATE ER?
- What are the global sales for METADATE ER?
- What is Average Wholesale Price for METADATE ER?
Summary for METADATE ER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| Clinical Trials: | 6 |
| Patent Applications: | 3,544 |
| Drug Prices: | Drug price information for METADATE ER |
| DailyMed Link: | METADATE ER at DailyMed |
Recent Clinical Trials for METADATE ER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Matthew O'Brien | Phase 4 |
| Matthew J O'Brien, PhD, BCBA-D | Phase 4 |
| Craig Rush | Early Phase 1 |
US Patents and Regulatory Information for METADATE ER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett Co Inc | METADATE ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 040306-001 | Oct 20, 1999 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Lannett Co Inc | METADATE ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 089601-001 | Jun 1, 1988 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
